Redefining the high‐grade B cell lymphoma with double/triple rearrangements of MYC and BCL2/BCL6 genes. Learning from a case report

Redefining the high‐grade B cell lymphoma with double/triple rearrangements of MYC and BCL2/BCL6 genes. Learning from a case report

Abstract We report a patient initially diagnosed with a triple hit high‐grade B cell lymphoma (HGBL‐TH), in which further morphologic, immunohistochemical, and next‐generation sequencing studies of subsequent specimens disclosed it to be a germinal center diffuse large B cell lymphoma (GC‐DLBCL) wit...

Full description

Bibliographic Details
Main Authors:	Socorro María Rodríguez‐Pinilla, Rocío Nieves Salgado, Cristina Chamizo, Carlos Santonja, Peter Stewart, Nerea Carvajal, Neil McCafferty, Rebeca Manso, Daniel Morillo, Miguel Ángel Piris, David González de Castro
Format:	Article
Language:	English
Published:	Wiley 2022-02-01
Series:	eJHaem
Subjects:	B‐cell lymphomas with double or triple hits fluorescence in situ hybridization follicular lymphoma MYC PVT1
Online Access:	https://doi.org/10.1002/jha2.310

Similar Items

Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors
by: Weiping Li, et al.
Published: (2019-07-01)

High-Grade B-Cell Lymphoma (HGBL) with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan
by: Cheng-Chih Tsai, et al.
Published: (2021-03-01)

High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma
by: Alison M. Moore, et al.
Published: (2018-05-01)

Copy Number Alteration and Mutational Profile of High-Grade B-Cell Lymphoma with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> Rearrangements, Diffuse Large B-Cell Lymphoma with <i>MYC</i>-Rearrangement, and Diffuse Large B-Cell Lymphoma with <i>MYC</i>-Cluster Amplification
by: Masashi Miyaoka, et al.
Published: (2022-11-01)

High-grade B-cell Lymphoma with <i>MYC</i> and <i>BCL2</i> Rearrangement Arising from Follicular Lymphoma: Presentation as a Large Peripancreatic Mass
by: Anna Shestakova, et al.
Published: (2020-03-01)

Clinicopathological analysis of DLBCL/HGBL with MYC, BCL2 and BCL6 gene rearrangement
by: WEI Jing, HE Yaqi, XUE Tian, BAI Qianming, SHUI Ruohong, LU Hongfen, LI Xiaoqiu, YU Baohua
Published: (2023-09-01)

Induction treatment in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: a systematic review and meta-analysis
by: Vanja Zeremski, et al.
Published: (2023-07-01)

Sequence based analysis of U-2973, a cell line established from a double-hit B-cell lymphoma with concurrent <it>MYC</it> and <it>BCL2</it> rearrangements
by: Hooper Sean D, et al.
Published: (2012-11-01)

MYC Immunohistochemistry Predicts MYC Rearrangements by FISH
by: Julum Nwanze, et al.
Published: (2017-09-01)

MYC overexpression but not MYC/BCL2 double expression predicts survival in bulky mass diffuse large B‐cell lymphoma patients
by: Yanjie Wang, et al.
Published: (2023-09-01)

Unusual presentation of extra-nodal double-hit follicular lymphoma: a case report
by: Stefano Lazzi, et al.
Published: (2022-05-01)

Case Report: Phenotypic Switch in High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements: A Potential Mechanism of Therapeutic Resistance in Lymphoma?
by: Hui Liu, et al.
Published: (2021-12-01)

Evaluation of the Prognostic Importance of c-Myc and Bcl-2 Expressions and the Presence of Epstein-Barr Virus in Classical Hodgkin Lymphoma
by: Aydan KILIÇARSLAN, et al.
Published: (2018-09-01)

Drug therapy for double-hit lymphoma
by: Vania Phuoc, et al.
Published: (2019-12-01)

Case Report: Concurrent Occurrence of Abdominal Double Expressor Lymphoma and Jejunum Follicular Lymphoma
by: Ryutaro Takada, et al.
Published: (2021-05-01)

High‐grade B‐cell lymphoma with MYC and BCL2 rearrangements with abundant multinucleated giant tumor cells
by: Man Zhang, et al.
Published: (2023-05-01)

Generation of a Murine Model for c-MYC and BCL2 Co-expression B Cell Lymphomas
by: Zhenming Cai, et al.
Published: (2020-06-01)

Immunophenotypic Landscape and Prognosis of Diffuse Large B-Cell Lymphoma with MYC/BCL2 Double Expression: An Analysis of A Prospectively Immunoprofiled Cohort
by: Bogyeong Han, et al.
Published: (2020-11-01)

Diffuse large B-cell lymphoma with concomitant c-MYC and BCL6 gene rearrangements with primary skin involvement: A case report and a review of literature
by: N G Gabeeva, et al.
Published: (2017-07-01)

Correlation Between C-MYC, BCL-2, and BCL-6 Protein Expression and Gene Translocation as Biomarkers in Diagnosis and Prognosis of Diffuse Large B-cell Lymphoma
by: YunXiang Zhang, et al.
Published: (2019-01-01)

Expression of PD-L1 and Its Clinical Significance in MYC/BCL2 Double-expression Large B Cell Lymphoma
by: WANG Ping, et al.
Published: (2020-01-01)

Skin lesions as the first manifestation of follicular lymphoma
by: Julia Nowowiejska, et al.
Published: (2023-11-01)

50% versus 70%: is there a difference between these BCL2 cut-offs in immunohistochemistry for diffuse large B-cell lymphomas (DLBCL)?
by: Cristiano Claudino Oliveira, et al.
Published: (2020-09-01)

MYC’s Fine Line Between B Cell Development and Malignancy
by: Oriol de Barrios, et al.
Published: (2020-02-01)

In situ follicular neoplasia/lymphoma: Three illustrative cases exemplifying unique disease presentations
by: Uma Sakhadeo, et al.
Published: (2012-01-01)

Pediatric-type follicular lymphoma
by: Anuj Verma, et al.
Published: (2022-03-01)

Systemic Inflammation and Tumour-Infiltrating T-Cell Receptor Repertoire Diversity Are Predictive of Clinical Outcome in High-Grade B-Cell Lymphoma with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> Rearrangements
by: Vito Olschewski, et al.
Published: (2021-02-01)

Decreased CD11c‐positive dendritic cells in the tumor microenvironment predict double‐hit/triple‐hit genotype and survival in diffuse large B‐cell lymphoma
by: Chang‐Tsu Yuan, et al.
Published: (2022-09-01)

Oxidative stress enhances the therapeutic action of a respiratory inhibitor in MYC‐driven lymphoma
by: Giulio Donati, et al.
Published: (2023-06-01)

Molecular Evaluation of t(14;18)(bcl-2/IgH) Translocation in Follicular Lymphoma at Diagnosis Using Paraffin-Embedded Tissue Sections
by: Nur Selvi, et al.
Published: (2012-05-01)

Composite follicular lymphoma and classic Hodgkin lymphoma
by: Han-Na Kim, et al.
Published: (2022-01-01)

Germinal Center Cells Turning to the Dark Side: Neoplasms of B Cells, Follicular Helper T Cells, and Follicular Dendritic Cells
by: Rosario Munguía-Fuentes, et al.
Published: (2021-01-01)

High-grade B-Cell lymphoma with MYC and BCL6 rearrangements associated with Richter transformation of chronic lymphocytic leukemia
by: Thomas S Rogers, et al.
Published: (2019-08-01)

Successful Clarithromycin Monotherapy in a Patient with Primary Follicular Lymphoma of the Duodenum
by: Barbara Kiesewetter, et al.
Published: (2018-04-01)

Lessons from Using Genetically Engineered Mouse Models of MYC-Induced Lymphoma
by: René Winkler, et al.
Published: (2022-12-01)

Clinical significance of bcl-2 protein in the progress of patients with follicular non-Hodgkin lymphoma.
by: ELENI GOVA
Published: (2014-08-01)

Primary testicular follicular lymphoma
by: Sofia Garces, et al.
Published: (2022-03-01)

Translating prognostic quantification of c-MYC and BCL2 from tissue microarrays to whole slide images in diffuse large B-cell lymphoma using deep learning
by: Thomas E. Tavolara, et al.
Published: (2024-01-01)

Ascites as First Atypical and Only Clinical Manifestation of De Novo Follicular Lymphoma
by: Natasa D. Zdravkovic, et al.
Published: (2022-10-01)

Radiotherapy for early and advanced stages Follicular Lymphoma
by: Geovanne Pedro Mauro, et al.
Published: (2021-01-01)